OpenFilings

Immix Biopharma, Inc.

Form10-K

Report Period2025-12-31

Date Filed2026-03-25

Time Filed17:19:13

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

10-K
EX-4.7
EX-10.27
EX-10.28
EX-19.1
EX-21.1
EX-23.1
EX-31.1
EX-31.2
EX-32.1
EX-99.1
Filing on SEC Edgar